Pilot Projects Program

试点项目计划

基本信息

  • 批准号:
    8948616
  • 负责人:
  • 金额:
    $ 55.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-01 至 2021-04-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT – PILOT PROJECTS PROGRAM Advancing the development of clinical and translational research in Rhode Island is a critical need. Rhode Island institutions have a tradition of providing Pilot Projects support, but these awards have generally not been designated to support clinical and translational research. Thus, there is an unmet need to enhance funding of Clinical and Translational Research in Rhode Island that would be met by the RI-CCTS. We propose establishment of a Pilot Project Grants Program that is trans-disciplinary and translational with the following Specific Aims: 1. Enhance the quality and quantity of clinical and translational research in Rhode Island by funding Pilot Projects spanning the research spectrum from T1 to T4 and by developing clinical and translational research collaborations of co-PI's. 2. Promote selected high impact clinical and translational research areas via Emerging Areas of Research Symposia at institutions in Rhode Island, in collaboration with existing INBRE and COBRE programs. In the Pilot Projects Program, junior investigators (or more senior investigators transitioning to a translational research focus) will have the opportunity to apply for small grants of one year duration with an option of applying for a second year. In order to stimulate interdisciplinary collaboration, each Pilot Project grant will have two co-PI's from different disciplines. Two senior investigators will be designated as mentors to advise on grant preparation and conduct of the research. One mentor will have specific background in methodology or basic science, and the other mentor will have clinical science expertise. At least one of the Pilot Projects awarded through the RI-CCTS each year will include a clinical trial. In order to stimulate Clinical and Translational Research in high impact areas, the Pilot Projects Program Advisory Committee will work with the IDeA programs funded in RI to develop an annual research symposium on relevant topics. Symposia sites will rotate among Brown University, the Affiliated Hospitals, and the University of Rhode Island. The Pilot Projects Program will be led by Sharon Rounds with Deputy Leader Michelle Lally. It will be supported by an Advisory Committee that includes representatives from the Lifespan and Care New England Hospital Systems, the Providence Veterans Affairs Medical Center, the University of Rhode Island, and Brown University. The Advisory Committee will oversee application and review processes and, in conjunction with the RI-CCTS Internal Advisory Committee (IAC), will determine prioritization of research topics. Particular attention will be paid to support of clinical and translational research in areas of health disparities in Rhode Island. The Pilot Projects Program will leverage professional development opportunities, functionality and facilities offered by other Key Components (KC) of the RI-CCTS. The Pilot Projects Program will be an integral part of the RI-CCTS, providing opportunities to perform collaborative Clinical and Translational Research and to interact with other investigators to stimulate new research.
摘要-试点项目 推进临床和转化研究在罗得岛的发展是一个关键的需要。罗德 岛屿机构有提供试点项目支助的传统,但这些奖项一般没有得到 用于支持临床和转化研究。因此,在增加对以下方面的供资方面的需求尚未得到满足: RI-CCTS将满足罗得岛的临床和转化研究。我们提出 建立一个跨学科和翻译的试点项目赠款计划,包括以下内容 具体目标:1。提高罗得岛临床和转化研究的质量和数量 通过资助涵盖T1至T4研究范围的试点项目, 共同主要研究者的临床和转化研究合作。2.促进选定的高影响力临床 和翻译研究领域通过研究研讨会的新兴领域在罗德岛的机构 岛,与现有的INBRE和COBRE计划合作。在试点项目中,初级 研究者(或更高级的研究者过渡到翻译研究重点)将有 有机会申请为期一年的小额赠款,并可选择申请第二年。为了 为了促进跨学科合作,每个试点项目赠款将有两个来自不同领域的联合PI 学科两名资深调查员将被指定为导师,就拨款的准备和实施提供意见 的研究。一位导师将具有方法学或基础科学的特定背景,另一位导师将具有方法学或基础科学的特定背景。 导师将具有临床科学专业知识。至少一个通过RI-CCTS授予的试点项目 每年将进行一次临床试验。为了刺激临床和转化研究的高影响力 在某些领域,试办计画计画谘询委员会将与国际扶轮资助的IDEA计画合作, 每年就相关主题举办一次研究专题讨论会。研讨会地点将在布朗大学, 附属医院和罗得岛大学。试点项目计划将由沙龙领导 与副领导人米歇尔·拉里(Michelle Lally)会面它将得到一个咨询委员会的支持,该委员会包括 来自寿命和护理新英格兰医院系统、普罗维登斯退伍军人事务部的代表 医学中心、罗得岛大学和布朗大学。咨询委员会将监督 申请和审查程序,并与RI-CCTS内部咨询委员会(IAC)一起,将 确定研究课题的优先次序。将特别注意支持临床和 在罗得岛的健康差距领域的转化研究。试点项目计划将利用 专业发展的机会,功能和设施提供的其他关键组成部分(KC)的 RI-CCTS。试点项目计划将是RI-CCTS的一个组成部分, 进行合作临床和转化研究,并与其他研究者互动,以促进 新的研究

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sharon Irene Smith Rounds其他文献

Sharon Irene Smith Rounds的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sharon Irene Smith Rounds', 18)}}的其他基金

RI-Center for Clinical and Translational Science
RI-临床和转化科学中心
  • 批准号:
    10413517
  • 财政年份:
    2021
  • 资助金额:
    $ 55.77万
  • 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
  • 批准号:
    10468390
  • 财政年份:
    2021
  • 资助金额:
    $ 55.77万
  • 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
  • 批准号:
    10681738
  • 财政年份:
    2021
  • 资助金额:
    $ 55.77万
  • 项目类别:
Pilot Projects Program
试点项目计划
  • 批准号:
    10281528
  • 财政年份:
    2016
  • 资助金额:
    $ 55.77万
  • 项目类别:
RI-Center for Clinical and Translational Science
RI-临床和转化科学中心
  • 批准号:
    10403751
  • 财政年份:
    2016
  • 资助金额:
    $ 55.77万
  • 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
  • 批准号:
    10595415
  • 财政年份:
    2016
  • 资助金额:
    $ 55.77万
  • 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
  • 批准号:
    10281523
  • 财政年份:
    2016
  • 资助金额:
    $ 55.77万
  • 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
  • 批准号:
    10466949
  • 财政年份:
    2016
  • 资助金额:
    $ 55.77万
  • 项目类别:
Pilot Projects Program
试点项目计划
  • 批准号:
    10466954
  • 财政年份:
    2016
  • 资助金额:
    $ 55.77万
  • 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
  • 批准号:
    10726129
  • 财政年份:
    2016
  • 资助金额:
    $ 55.77万
  • 项目类别:

相似海外基金

ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
  • 批准号:
    10935820
  • 财政年份:
    2023
  • 资助金额:
    $ 55.77万
  • 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
  • 批准号:
    10932514
  • 财政年份:
    2023
  • 资助金额:
    $ 55.77万
  • 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
  • 批准号:
    10704845
  • 财政年份:
    2023
  • 资助金额:
    $ 55.77万
  • 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
  • 批准号:
    10709085
  • 财政年份:
    2023
  • 资助金额:
    $ 55.77万
  • 项目类别:
Advanced Development of Gemini-DHAP
Gemini-DHAP的高级开发
  • 批准号:
    10760050
  • 财政年份:
    2023
  • 资助金额:
    $ 55.77万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 55.77万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10710595
  • 财政年份:
    2022
  • 资助金额:
    $ 55.77万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 55.77万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
  • 批准号:
    10710588
  • 财政年份:
    2022
  • 资助金额:
    $ 55.77万
  • 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
  • 批准号:
    10788051
  • 财政年份:
    2022
  • 资助金额:
    $ 55.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了